|
2020
|
Invention
|
Method for preparing coumarin compounds substituted by amidoalkyl at 3-position, the products and... |
|
|
Invention
|
A method for preparing coumarin compounds substituted by amidoalkyl at 3-position, the products a... |
|
|
Invention
|
Method for preparing coumarin compound, 3 position of which is substituted with amidoalkyl and pr... |
|
2019
|
Invention
|
Ire1a inhibitor in combination with cancer therapeutic agent for cancer treatment.
Provided are ... |
|
|
Invention
|
Ire1a inhibitor in combination with cancer therapeutic agent for cancer treatment. Provided are a... |
|
|
Invention
|
Ire-1α inhibitors. Compounds which directly inhibit IRE-1α activity in vitro, prodrugs, and pharm... |
|
2018
|
Invention
|
Ire1α inhibitor in combination with cancer therapeutic agent for cancer treatment. Provided are a... |
|
2016
|
Invention
|
Ire-1alpha inhibitors. The invention provides compounds which directly inhibit IRE-1α activity in... |
|
2011
|
Invention
|
Ire-1α substrates. IRE-1α substrates useful for identifying agonists and antagonists of IRE-1α RN... |
|
|
Invention
|
Ire-1.alpha. inhibitors. Compounds which directly inhibit IRE-1 ot activity in vitro, prodrugs, a... |
|
2010
|
Invention
|
Ire-1α inhibitors. The invention provides compounds which directly inhibit IRE-1α activity in vit... |
|
|
Invention
|
Ire-1.alpha. inhibitors. Compounds which directly inhibit IRE-1.alpha. activity in vitro, prodrug... |
|
|
Invention
|
Ire-1.alpha. inhibitors. The invention provides compounds which directly inhibit IRE-1a activity ... |
|
2008
|
Invention
|
Ire-1.alpha. inhibitors. Compounds which directly inhibit IRE- 1.alpha. activity in vitro, prodru... |
|
|
Invention
|
Ire-1.alpha. inhibitors. Compounds which directly inhibit IRE-la activity in vitro, prodrugs, and... |
